[Remote] Sr Bioinformatics Scientist at Tempus

Illinois, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, PharmaceuticalsIndustries

Requirements

Ph.D. in Bioinformatics, Computational Biology, Cancer Biology, Genetics, Immunology, Molecular Biology, or Computer Science
5-10 years of industry or academic experience
Computational skills using Python and/or R
Proven scientific reputation with publications and/or product development contributions
Expertise in developing NGS pipelines using contemporary tools
In-depth knowledge of creating statistical models and developing predictive/prognostic algorithms
Demonstrated effective communication and presentation skills
Self-driven and ability to work well in interdisciplinary teams

Responsibilities

Develop novel assays, algorithms, machine learning and statistical models to detect oncology related biomarkers from cell free next-generation sequencing (NGS) data
Design and conduct analyses applying deep genomic and epigenomic knowledge to derive key insights from large multi-modal datasets
Design and execute experiments to characterize performance and support regulatory submissions
Produce high quality and detailed documentation for all projects
Communicate results with scientific, product, and bioinformatics leadership
Lead, mentor, and/or train other scientists and engineers

Skills

Bioinformatics

Computational Biology

Genomics

Statistical Modeling

Machine Learning

NGS Data Analysis

Python

Deep Learning

Data Analysis

Experimental Design

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free